Sugi Predict

Sugi Predict / Compounds / Methacrylic Acid

Methacrylic Acid

Methacrylic Acid

SCHEMBL76432

C=C(C)C(=O)O.CC(C=Cc1ccccc1)=Cc1ccccc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GLA P06280 1/20 0.58
▸ TDP1 Q9NUW8 1/20 0.58
▸ ALDH1A1 P00352 3/20 0.53
▸ TSHR P16473 1/20 0.53
▸ AKR1C3 P42330 1/20 0.53
▸ MAPT P10636 4/20 0.52
▸ LMNA P02545 3/20 0.52
▸ HDAC3 O15379 2/20 0.52
▸ HDAC4 P56524 2/20 0.52
▸ HDAC1 Q13547 2/20 0.52
▸ HDAC2 Q92769 2/20 0.52
▸ HDAC8 Q9BY41 2/20 0.52
▸ HDAC6 Q9UBN7 2/20 0.52
▸ PLIN1 O60240 2/20 0.52
▸ RECQL P46063 2/20 0.52
▸ PLIN5 Q00G26 2/20 0.52
▸ ABHD5 Q8WTS1 2/20 0.52
▸ TNKS O95271 1/20 0.52
▸ HCAR2 Q8TDS4 1/20 0.52
▸ HDAC7 Q8WUI4 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3084338 0.87 ALDH1A1 (0.61) GLATDP1ALDH1A1TSHRAKR1C3
SCHEMBL23457945 0.87 ALDH1A1 (0.61) GLATDP1ALDH1A1TSHRAKR1C3
SCHEMBL29382 0.87 ALDH1A1 (0.61) GLATDP1ALDH1A1TSHRAKR1C3
Methacrylic Acid SCHEMBL3795998 0.85 GLA (0.53) GLATDP1ALDH1A1TSHRAKR1C3
(Z)-1,2-Diphenylethene SCHEMBL3017352 0.85 GLA (0.59) GLATDP1ALDH1A1AKR1C3MAPT
(Z)-1,2-Diphenylethene SCHEMBL9983047 0.85 GLA (0.59) GLATDP1ALDH1A1AKR1C3MAPT
(Z)-1,2-Diphenylethene SCHEMBL3017350 0.85 GLA (0.59) GLATDP1ALDH1A1AKR1C3MAPT
Methacrylic Acid SCHEMBL29048486 0.84 TDP1 (0.60) GLATDP1ALDH1A1AKR1C3MAPT
Methacrylic Acid SCHEMBL6908387 0.84 TDP1 (0.60) GLATDP1ALDH1A1AKR1C3MAPT
Methacrylic Acid SCHEMBL1618411 0.82 HDAC3 (0.53) GLATDP1ALDH1A1TSHRAKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9732227-B2 Modified colorants and inkjet ink compositions comprising modified colorants CABOT CORPORATION (US) 2017-08-15 — — US disclosed
US-20160075880-A1 Modified Colorants and Inkjet Ink Compositions Comprising Modified Colorants CABOT CORPORATION 2016-03-17 — — US disclosed
EP-2431425-B1 Modified colorants and inkjet ink compositions comprising modified colorants CABOT CORP (US) 2015-03-11 — — EP disclosed
EP-2431427-B1 Modified colorants and inkjet ink compositions comprising modified colorants CABOT CORP (US) 2014-12-31 — — EP disclosed
US-8858695-B2 Modified colorants and inkjet ink compositions comprising modified colorants CABOT CORPORATION (US) 2014-10-14 — — US disclosed
US-8697774-B2 Ink for ink jet recording and ink set for ink jet recording SEIKO EPSON CORPORATION (JP) 2014-04-15 — — US disclosed
US-20120232203-A1 INK FOR INK JET RECORDING AND INK SET FOR INK JET RECORDING SEIKO EPSON CORPORATION (JP) 2012-09-13 — — US disclosed
EP-2431426-A1 Modified colorants and inkjet ink compositions comprising modified colorants Cabot Corporation (US) 2012-03-21 — — EP disclosed
EP-2431427-A1 Modified colorants and inkjet ink compositions comprising modified colorants Cabot Corporation (US) 2012-03-21 — — EP disclosed
EP-2431425-A1 Modified colorants and inkjet ink compositions comprising modified colorants Cabot Corporation (US) 2012-03-21 — — EP disclosed
US-20070179215-A1 Inkjet ink compositions comprising polymeric dispersants having attached chromophore groups CABOT CORPORATION 2007-08-02 — — US disclosed
US-20070179214-A1 Inkjet ink compositions comprising polymeric dispersants having attached chromophore groups CABOT CORPORATION 2007-08-02 — — US disclosed
WO-2007053564-A2 MODIFIED COLORANTS AND INKJET INK COMPOSITIONS COMPRISING MODIFIED COLORANTS CABOT CORPORATION (US) 2007-05-10 — — WO disclosed
US-20070100024-A1 Modified colorants and inkjet ink compositions comprising modified colorants CABOT CORPORATION 2007-05-03 — — US disclosed
WO-2007047975-A2 METHOD OF PREPARING YELLOW PIGMENTS CABOT CORPORATION (US) 2007-04-26 — — WO disclosed
US-20070089641-A1 Method of preparing yellow pigments CABOT CORPORATION 2007-04-26 — — US disclosed
WO-2007027625-A2 PROCESS FOR PREPARING MODIFIED PIGMENTS CABOT CORPORATION (US) 2007-03-08 — — WO disclosed
US-20070044682-A1 Process for preparing modified pigments CABOT CORPORATION 2007-03-01 — — US disclosed
US-20060211791-A1 Inkjet inks comprising modified pigments having attached polymeric groups CABOT CORPORATION 2006-09-21 — — US disclosed
WO-2006086660-A1 INKJET INKS COMPRISING MODIFIED PIGMENTS HAVING ATTACHED POLYMERIC GROUPS CABOT CORPORATION (US) 2006-08-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070089641-A1 Method of preparing yellow pigments TYR, NQO2, RB1 GLA 2740/4885TDP1 2895/4885ALDH1A1 1681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.